Please assess the completion status of the following clinical trial:

Trial Title: Totally Endoscopic Ablation of Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \> 50 years~2. Longstanding persistent AF of \> 1 year duration~3. Severe symptoms related to AF~4. Have signed and dated Informed Consent.~5. Willing and able to comply with the protocol for the duration of the trial.~Exclusion Criteria:~1. Severe ischemic heart disease or heart valve disease~2. Thrombus formation in left atrial appendage~3. Intolerance to warfarin medication~4. Advanced pulmonary disease, FEV 1 \< 1.5 litre~5. Left atrial diameter \> 60 mm~6. Body Mass Index (BMI) \> 35 kg/m2~7. Previous pulmonary or heart surgery~8. Participation in another clinical trial within the last 30 days prior to enrollment

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Endoscopic ablation of atrial fibrillation (Type: EXPERIMENTAL): None
- Rate control (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).